Related Experiment Video
Updated: Jan 4, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Updated leg ulcer pathway: improving healing times and reducing costs
Leanne Atkin1, Alison Schofield2, Anita Kilroy-Findley3
1Vascular Nurse Consultant, Mid Yorkshire NHS Trust/University of Huddersfield.
Implementing a standardized leg ulcer pathway improved healing times and reduced costs for venous leg ulcers (VLUs). This approach ensures timely patient assessment, enhancing quality of life and optimizing nursing resources.
Area of Science:
- Vascular medicine
- Nursing practice
- Health services research
Background:
- Significant variations exist in current leg ulcer management despite extensive evidence.
- Suboptimal treatment protocols can lead to prolonged healing times and increased healthcare costs.
Purpose of the Study:
- To evaluate the impact of a standardized leg ulcer pathway on treatment outcomes.
- To assess the pathway's effect on nursing time, costs, and patient quality of life.
Main Methods:
- Introduction of a standardized pathway for venous leg ulcer (VLU) assessment and treatment in Lincolnshire and Leicestershire, UK.
- Data collection on healing times, costs, and nurse visit frequency.
Main Results:
- The standardized pathway led to improved VLU healing times.
- A reduction in overall treatment costs was observed.
- Fewer nurse visits were required for patient management.
Conclusions:
- Standardized leg ulcer pathways are effective in improving VLU healing outcomes.
- Implementation can lead to significant cost savings and efficient use of nursing resources.
- This approach enhances patient quality of life through timely and appropriate care.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
